Active thrombin produced by the intestinal epithelium controls mucosal biofilms.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
19 07 2019
Historique:
received: 22 11 2018
accepted: 25 06 2019
entrez: 21 7 2019
pubmed: 22 7 2019
medline: 18 12 2019
Statut: epublish

Résumé

Proteolytic homeostasis is important at mucosal surfaces, but its actors and their precise role in physiology are poorly understood. Here we report that healthy human and mouse colon epithelia are a major source of active thrombin. We show that mucosal thrombin is directly regulated by the presence of commensal microbiota. Specific inhibition of luminal thrombin activity causes macroscopic and microscopic damage as well as transcriptomic alterations of genes involved in host-microbiota interactions. Further, luminal thrombin inhibition impairs the spatial segregation of microbiota biofilms, allowing bacteria to invade the mucus layer and to translocate across the epithelium. Thrombin cleaves the biofilm matrix of reconstituted mucosa-associated human microbiota. Our results indicate that thrombin constrains biofilms at the intestinal mucosa. Further work is needed to test whether thrombin plays similar roles in other mucosal surfaces, given that lung, bladder and skin epithelia also express thrombin.

Identifiants

pubmed: 31324782
doi: 10.1038/s41467-019-11140-w
pii: 10.1038/s41467-019-11140-w
pmc: PMC6642099
doi:

Substances chimiques

Thrombin EC 3.4.21.5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3224

Références

J Thromb Haemost. 2003 Jul;1(7):1504-14
pubmed: 12871286
Inflamm Bowel Dis. 2015 May;21(5):1006-17
pubmed: 25738373
Indian J Med Res. 2017 Jul;146(Supplement):S1-S8
pubmed: 29205189
Exp Anim. 2007 Jul;56(4):273-8
pubmed: 17660681
J Clin Invest. 2007 Mar;117(3):636-47
pubmed: 17304351
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):E9105-E9114
pubmed: 29073107
Inflamm Bowel Dis. 2018 Jun 8;24(7):1493-1502
pubmed: 29788224
Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):11002-7
pubmed: 22711827
J Clin Microbiol. 1999 Jun;37(6):1771-6
pubmed: 10325322
J Clin Microbiol. 2005 Jul;43(7):3380-9
pubmed: 16000463
Microb Biotechnol. 2015 May;8(3):392-403
pubmed: 25154775
Am J Pathol. 2012 Jan;180(1):141-52
pubmed: 22067907
Proc Natl Acad Sci U S A. 2017 May 23;114(21):E4213-E4222
pubmed: 28473418
Am J Physiol Lung Cell Mol Physiol. 2015 Jun 15;308(12):L1189-201
pubmed: 25888573
Gut. 2016 Jul;65(7):1215-24
pubmed: 27196587
Curr Opin Pharmacol. 2006 Aug;6(4):428-34
pubmed: 16777485
Ultrastruct Pathol. 2004 Jan-Feb;28(1):23-7
pubmed: 14967595
Annu Rev Med. 2008;59:415-28
pubmed: 17937586
PLoS Pathog. 2010 Apr 22;6(4):e1000857
pubmed: 20421939
Biol Reprod. 2002 May;66(5):1350-8
pubmed: 11967197
Gastroenterology. 2011 Apr;140(4):1272-82
pubmed: 21199654
Cancer Invest. 2011 Jan;29(1):62-7
pubmed: 21166500
Am J Physiol Lung Cell Mol Physiol. 2018 Dec 1;315(6):L1003-L1014
pubmed: 30284925
Adv Appl Microbiol. 2011;75:111-43
pubmed: 21807247
J Microbiol Methods. 2010 Dec;83(3):296-301
pubmed: 20920538
Appl Environ Microbiol. 2013 Feb;79(4):1393-5
pubmed: 23220967
Tissue Barriers. 2017 Jan 2;5(1):e1274354
pubmed: 28452685
BMC Microbiol. 2015 Oct 09;15:207
pubmed: 26453184
Biologics. 2008 Sep;2(3):481-90
pubmed: 19707378
Sci Transl Med. 2012 Oct 31;4(158):158ra144
pubmed: 23115353
Thromb Haemost. 2011 Dec;106(6):1020-33
pubmed: 21979864
Sci Rep. 2018 May 18;8(1):7834
pubmed: 29777136
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt B):2220-2227
pubmed: 28797647
Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8363-8
pubmed: 15919826
Br J Pharmacol. 2018 Sep;175(18):3656-3668
pubmed: 29959891
Nat Genet. 2005 Jan;37(1):56-65
pubmed: 15619623
Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18321-6
pubmed: 25489084
Nat Commun. 2011 Feb 08;2:190
pubmed: 21304519
Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):615-21
pubmed: 22949490
Mol Syst Biol. 2017 Mar 16;13(3):921
pubmed: 28302863
Clin Toxicol (Phila). 2012 Aug;50(7):571-3
pubmed: 22800505
Am J Physiol Gastrointest Liver Physiol. 2018 Feb 1;314(2):G143-G149
pubmed: 29025733
Gut. 2017 Oct;66(10):1767-1778
pubmed: 28096305
J Pharmacol Toxicol Methods. 1995 Aug;33(4):237-9
pubmed: 8527832
Annu Rev Nutr. 2005;25:127-49
pubmed: 16011462
World J Gastroenterol. 2005 Feb 28;11(8):1131-40
pubmed: 15754393
Am J Pathol. 2010 Apr;176(4):1600-6
pubmed: 20150433
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
Nature. 2010 May 20;465(7296):346-9
pubmed: 20485435
Nat Biotechnol. 2010 Mar;28(3):281-8
pubmed: 20208520
Lancet. 1980 Jan 5;1(8158):39-40
pubmed: 6101371
Science. 2018 Feb 2;359(6375):592-597
pubmed: 29420293
Biochim Biophys Acta. 2012 Jan;1824(1):246-52
pubmed: 21782041
Nat Protoc. 2011 Sep 22;6(10):1578-611
pubmed: 21959240
Science. 1999 May 21;284(5418):1318-22
pubmed: 10334980
Med Sci (Paris). 2010 Aug-Sep;26(8-9):681-5
pubmed: 20819697
Nat Methods. 2014 Feb;11(2):121-2
pubmed: 24481215

Auteurs

Jean-Paul Motta (JP)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, U1220, CHU Purpan, CS60039, 31024, Toulouse, France.

Alexandre Denadai-Souza (A)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, U1220, CHU Purpan, CS60039, 31024, Toulouse, France.

David Sagnat (D)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, U1220, CHU Purpan, CS60039, 31024, Toulouse, France.

Laura Guiraud (L)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, U1220, CHU Purpan, CS60039, 31024, Toulouse, France.

Anissa Edir (A)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, U1220, CHU Purpan, CS60039, 31024, Toulouse, France.

Chrystelle Bonnart (C)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, U1220, CHU Purpan, CS60039, 31024, Toulouse, France.

Mireille Sebbag (M)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, U1220, CHU Purpan, CS60039, 31024, Toulouse, France.

Perrine Rousset (P)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, U1220, CHU Purpan, CS60039, 31024, Toulouse, France.

Ariane Lapeyre (A)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, U1220, CHU Purpan, CS60039, 31024, Toulouse, France.

Carine Seguy (C)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, U1220, CHU Purpan, CS60039, 31024, Toulouse, France.

Noa Mathurine-Thomas (N)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, U1220, CHU Purpan, CS60039, 31024, Toulouse, France.

Heather J Galipeau (HJ)

Farncombe Family Digestive Health Research Institute, McMaster University, Health Science Center, Rm 3N4, 1280 Main Street West, Hamilton, ON, L8S 4K1, Canada.

Delphine Bonnet (D)

Department of Internal Medicine and Digestive Diseases, 1, avenue Jean Poulhes-TSA 50032, 31059, Toulouse, France.

Laurent Alric (L)

Department of Internal Medicine and Digestive Diseases, 1, avenue Jean Poulhes-TSA 50032, 31059, Toulouse, France.

Andre G Buret (AG)

Department of Biological Sciences, University of Calgary, 2500 University Drive NW, Calgary, Ab, T2N 4N1, Canada.

John L Wallace (JL)

Departments of Physiology & Pharmacology, and Medicine, University of Calgary Cumming School of Medicine, 3330 Hospital Drive NW, Calgary, Ab, T2N 4N1, Canada.

Antoine Dufour (A)

Departments of Physiology & Pharmacology, and Medicine, University of Calgary Cumming School of Medicine, 3330 Hospital Drive NW, Calgary, Ab, T2N 4N1, Canada.

Elena F Verdu (EF)

Farncombe Family Digestive Health Research Institute, McMaster University, Health Science Center, Rm 3N4, 1280 Main Street West, Hamilton, ON, L8S 4K1, Canada.

Morley D Hollenberg (MD)

Departments of Physiology & Pharmacology, and Medicine, University of Calgary Cumming School of Medicine, 3330 Hospital Drive NW, Calgary, Ab, T2N 4N1, Canada.

Eric Oswald (E)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, U1220, CHU Purpan, CS60039, 31024, Toulouse, France.

Matteo Serino (M)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, U1220, CHU Purpan, CS60039, 31024, Toulouse, France.

Celine Deraison (C)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, U1220, CHU Purpan, CS60039, 31024, Toulouse, France.

Nathalie Vergnolle (N)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, U1220, CHU Purpan, CS60039, 31024, Toulouse, France. nathalie.vergnolle@inserm.fr.
Departments of Physiology & Pharmacology, and Medicine, University of Calgary Cumming School of Medicine, 3330 Hospital Drive NW, Calgary, Ab, T2N 4N1, Canada. nathalie.vergnolle@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH